Literature DB >> 16538108

Soluble triggering receptor expressed on myeloid cells (sTREM-1): a new mediator involved in the pathogenesis of peptic ulcer disease.

Vassilios Koussoulas1, Spyridon Vassiliou, Maria Demonakou, Georgios Tassias, Evangelos J Giamarellos-Bourboulis, Maria Mouktaroudi, Helen Giamarellou, Charalambos Barbatzas.   

Abstract

OBJECTIVES: Triggering receptor expressed on myeloid cells (TREM-1) is a promoter of cytokine production triggered by microbial components. To investigate the significance of its soluble counterpart, sTREM-1, for the pathogenesis of peptic ulcer disease, sTREM-1 was compared with the proinflammatory mediators and the pathology score of gastritis.
METHODS: Forty patients with dyspepsia were enrolled: 20 with peptic ulcer and 20 controls without any macroscopic abnormalities. All patients were examined by endoscopy; gastric juice was aspirated and biopsy specimens were collected from the antrum and corpus of the stomach. sTREM-1 was estimated by a hand-made enzyme immunoassay. Interleukin-8 was estimated by enzyme-linked immunosorbent assay and lipid peroxidation, indexed by malondialdehyde, by the thiobarbituric assay, after passage through a high-performance liquid chromatography system.
RESULTS: The median (+/-SE) of sTREM-1 of controls and patients with ulcer was 3.91+/-0.57 and 44.27+/-241.55 RU, respectively (P=0.006). The median (+/-SE) of interleukin-8 of controls and patients with ulcer was 1802.97+/-122.10 and 2030.66+/-64.44 pg/ml, respectively (P=0.023). sTREM-1 was positively correlated with the density of neutrophil and mononuclear infiltration scores and the total Sydney score (P=0.029, 0.043 and 0.041, respectively). sTREM-1 was positively correlated with interleukin-8 (P=0.042).
CONCLUSIONS: sTREM-1 might be an independent factor involving with the peptic ulcerative inflammatory process that is positively correlated with histopathological abnormalities of gastritis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16538108     DOI: 10.1097/00042737-200604000-00010

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  17 in total

1.  Serum sTREM-1 as a surrogate marker of treatment outcome in patients with peptic ulcer disease.

Authors:  Vassilios Koussoulas; Evangelos J Giamarellos-Bourboulis; Charalambos Barbatzas; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2011-06-02       Impact factor: 3.199

2.  Identification of a Novel Splice Variant Isoform of TREM-1 in Human Neutrophil Granules.

Authors:  Sankar Baruah; Kathy Keck; Michelle Vrenios; Marshall R Pope; Merideth Pearl; Kevin Doerschug; Julia Klesney-Tait
Journal:  J Immunol       Date:  2015-11-11       Impact factor: 5.422

3.  Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease.

Authors:  Michalis Tzivras; Vassilios Koussoulas; Evangelos J Giamarellos-Bourboulis; Dimitrios Tzivras; Thomas Tsaganos; Pantelis Koutoukas; Helen Giamarellou; Athanasios Archimandritis
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

4.  Tumor necrosis factor-α regulates triggering receptor expressed on myeloid cells-1-dependent matrix metalloproteinases in the carotid plaques of symptomatic patients with carotid stenosis.

Authors:  Velidi H Rao; Vikrant Rai; Samantha Stoupa; Saravanan Subramanian; Devendra K Agrawal
Journal:  Atherosclerosis       Date:  2016-03-19       Impact factor: 5.162

5.  Blockade of TREM-1 prevents vitreoretinal neovascularization in mice with oxygen-induced retinopathy.

Authors:  Modesto A Rojas; Zu T Shen; Ruth B Caldwell; Alexander B Sigalov
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-05-03       Impact factor: 5.187

6.  Amniotic fluid sTREM-1 in normal pregnancy, spontaneous parturition at term and preterm, and intra-amniotic infection/inflammation.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Tinnakorn Chaiworapongsa; Pooja Mittal; Shali Mazaki-Tovi; Edi Vaisbuch; Offer Erez; Francesca Gotsch; Nandor Gabor Than; Sam S Edwin; Percy Pacora; Cristiano Jodicke; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-01

Review 7.  TREM and TREM-like receptors in inflammation and disease.

Authors:  Jill W Ford; Daniel W McVicar
Journal:  Curr Opin Immunol       Date:  2009-02-21       Impact factor: 7.486

8.  Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease.

Authors:  Vassilios Koussoulas; Spyridon Vassiliou; Ekaterini Spyridaki; Maria Demonakou; Ilia Vaki; Charalambos Barbatzas; Helen Giamarellou; Evangelos J Giamarellos-Bourboulis
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

9.  Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease.

Authors:  Jae Jun Park; Jae Hee Cheon; Bo Young Kim; Duk Hwan Kim; Eun Soo Kim; Tae Il Kim; Kyoung Ryul Lee; Won Ho Kim
Journal:  Dig Dis Sci       Date:  2008-10-31       Impact factor: 3.199

10.  Can soluble triggering receptor expressed on myeloid cells (sTREM-1) be considered an anti-inflammatory mediator in the pathogenesis of peptic ulcer disease?

Authors:  Vassilios Koussoulas; Michalis Tzivras; Evangelos J Giamarellos-Bourboulis; Maria Demonakou; Spyridon Vassilliou; Aimilia Pelekanou; Antonios Papadopoulos; Helen Giamarellou; Charalambos Barbatzas
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.